Capital Square’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,520
Closed -$190K 148
2022
Q3
$190K Buy
14,520
+271
+2% +$4K 0.17% 121
2022
Q2
$199K Buy
14,249
+415
+3% +$5.55K 0.17% 130
2022
Q1
$206K Buy
13,834
+307
+2% +$4.2K 0.15% 137
2021
Q4
$189K Sell
13,527
-8,033
-37% -$114K 0.13% 146
2021
Q3
$322K Sell
21,560
-7,688
-26% -$130K 0.23% 117
2021
Q2
$543K Sell
29,248
-1,444
-5% -$25.7K 0.4% 76
2021
Q1
$550K Sell
30,692
-867
-3% -$15.2K 0.41% 76
2020
Q4
$548K Sell
31,559
-208
-0.7% -$3.32K 0.46% 69
2020
Q3
$437K Buy
31,767
+617
+2% +$9.06K 0.45% 75
2020
Q2
$449K Buy
31,150
+977
+3% +$12.8K 0.48% 74
2020
Q1
$329K Buy
30,173
+8,691
+40% +$160K 0.38% 78
2019
Q4
$458K Buy
+21,482
New +$481K 0.44% 73

Other funds holding SBRA

Capital Square's SBRA Position: Q4 2022 in Review

Capital Square sold out of Sabra Healthcare REIT (SBRA) in Q4 2022, closing a stake of 14,520 shares — an estimated $190K sold.

Capital Square first reported a position in SBRA in Q4 2019 and held it in 12 quarters. The position peaked at $550K in Q1 2021. 327 funds tracked by Wall St. Rank hold SBRA as of Q4 2022.

  • Capital Square reported no remaining Sabra Healthcare REIT position as of Q4 2022 after selling out during the quarter.
  • Capital Square sold 14,520 Sabra Healthcare REIT shares in Q4 2022, an estimated $190K.
  • Capital Square first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 12 quarters.
  • Capital Square's Sabra Healthcare REIT position peaked at $550K in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2022.

Based on Capital Square's 13F filing for Q4 2022, filed 10 Feb 2023.